BSE filing, NSE: INTEGFD. Summary written from the filing by ALFA Finder's alert engine.
Integrated Proteins Ltd: key numbers
- Share price
- ₹13.65
- Market cap
- ₹255.4 Cr
- Revenue (annual)
- ₹9.94 Cr
- Net profit (annual)
- ₹0.22 Cr
- P/E (TTM)
- 406.2×Sector 38.3×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Integrated Proteins Ltd
All →Integrated Proteins Management Change
Integrated Proteins appointed Ms. Arushi Aggarwal as Company Secretary and Compliance Officer, effective 29 October 2026. The appointment was approved at a board meeting as a Key Managerial Personnel change.
Integrated Proteins Management Change
Integrated Proteins Limited appointed Sandeep Mahadik as Non-Executive Independent Director and Ankita Shah as Secretarial Auditor, both effective September 30, 2026.
Integrated Proteins Annual General Meeting
Integrated Proteins Ltd held its Annual General Meeting on September 30, 2026. Shareholders considered resolutions regarding financial statements and company appointments.
Integrated Proteins Annual General Meeting
Integrated Proteins Ltd has announced its 33rd Annual General Meeting scheduled for September 30, 2026, via video conferencing to transact business including financial statement adoption.
Integrated Proteins Annual Report
Integrated Proteins Limited has released its 33rd Annual Report for the financial year 2025-26, containing financial statements and details for the upcoming annual general meeting.
Integrated Proteins Capital Structure Change
Integrated Proteins Limited has been assigned a new ISIN, INE177M01021, following a stock split. The change is effective from September 4, 2026.
Other other announcement announcements
All →Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.
Man Infraconstruction Other Announcement
Man Infraconstruction filed a Reg 32 quarterly statement confirming no deviation in use of preferential-warrant proceeds. No deviation or variation arose for the quarter ended September 30, 2026.
Black Buck Other Announcement
BlackBuck's ICRA monitoring agency report for Q1 FY27 confirms IPO proceeds utilization remains in line with stated objects. No deviation was observed in the quarter.
Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.